Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens

Computational prediction of new CYP17 inhibitors based on pharmacophore modeling, virtual screening and docking approach.

Die Pharmazie·2018

In vitro reconstitution of α-pyrone ring formation in myxopyronin biosynthesis.

Chemical science·2018

Steering the azido-tetrazole equilibrium of 4-azidopyrimidines via substituent variation - implications for drug design and azide-alkyne cycloadditions.

Organic & biomolecular chemistry·2015

Inhibition of 5 α-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR102 (Urtica dioica) extracts.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2012

Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.

European journal of medicinal chemistry·2012

Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates.

Journal of viral hepatitis·2010

"Current approaches and emerging strategies in the treatment of ductal carcinoma in situ and premalignant breast lesions".

Cancer treatment reviews·2026

Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.

Cancer treatment reviews·2026

Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel.

Cancer treatment reviews·2026

p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.

Cancer treatment reviews·2026

Selective estrogen receptor degraders in premenopausal breast cancer: Biological activity and endpoint relevance in window of opportunity trials.

Cancer treatment reviews·2026

From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.

Cancer treatment reviews·2026

Multi-omics integration identifies Acsm2/ACSM2A deficiency as a metabolic driver of ZBP1-mediated PANoptosis in acute kidney injury.

Frontiers in cell and developmental biology·2026

HER2 amplification as a resistance mechanism to osimertinib and its successful treatment with trastuzumab deruxtecan: a case report.

Frontiers in oncology·2026

Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma.

bioRxiv : the preprint server for biology·2026

Direct Coronary Vascular and Lipidomic Remodeling by Low-Dose GLP-1 Agonist Therapy in Cardiometabolic HFpEF.

Research square·2026

From Computational Prediction to In Vivo Experimental Validation: A Translational AI Pipeline for Anthracycline-Induced Cardiotoxicity.

Research square·2026

LncRNA-mediated organization of oncogenic chromatin state is a targetable vulnerability in leukemia.

bioRxiv : the preprint server for biology·2026

Related Experiment Videos

Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens

Related Concept Videos

Computational prediction of new CYP17 inhibitors based on pharmacophore modeling, virtual screening and docking approach.

In vitro reconstitution of α-pyrone ring formation in myxopyronin biosynthesis.

Steering the azido-tetrazole equilibrium of 4-azidopyrimidines via substituent variation - implications for drug design and azide-alkyne cycloadditions.

Inhibition of 5 α-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR102 (Urtica dioica) extracts.

Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.

Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates.

"Current approaches and emerging strategies in the treatment of ductal carcinoma in situ and premalignant breast lesions".

Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.

Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel.

p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.

Selective estrogen receptor degraders in premenopausal breast cancer: Biological activity and endpoint relevance in window of opportunity trials.

From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.

Multi-omics integration identifies Acsm2/ACSM2A deficiency as a metabolic driver of ZBP1-mediated PANoptosis in acute kidney injury.

HER2 amplification as a resistance mechanism to osimertinib and its successful treatment with trastuzumab deruxtecan: a case report.

Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma.

Direct Coronary Vascular and Lipidomic Remodeling by Low-Dose GLP-1 Agonist Therapy in Cardiometabolic HFpEF.

From Computational Prediction to In Vivo Experimental Validation: A Translational AI Pipeline for Anthracycline-Induced Cardiotoxicity.

LncRNA-mediated organization of oncogenic chromatin state is a targetable vulnerability in leukemia.

Related Experiment Videos

Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens

Related Concept Videos

Related Articles